Skip to content
Medical Health Aged Care

The Personalized Lifestyle Medicine Institute Announces the 11th Annual Thought Leaders Consortium

Personalized Lifestyle Medicine Institute 3 mins read

SEATTLE, WA / ACCESSWIRE / August 22, 2023 / The Personalized Lifestyle Medicine Institute (PLMI) is excited to bring together researchers, clinicians, industry leaders, and anyone interested in Functional Medicine for its 11th Annual Thought Leaders Consortium: Next Generation Clinical Management of Chronic Neuroimmune Disorders this October in Seattle, WA.

Personalized Lifestyle Medicine Institute
Personalized Lifestyle Medicine Institute
11th Annual Thought Leaders Consortium


The two-day event, located at the Seattle Marriott Waterfront, features leading innovators in the application of next-generation approaches for managing complex chronic neuroimmune disorders and will focus on recent discoveries and how to translate this information into clinical practice.

The program will explore the root causes of illness, the complexity of genetic and epigenetic influences, and the power of lifestyle, diet, and environmental and social factors that can impact therapeutic outcomes, with an emphasis on skill development, faculty interaction, and dynamic attendee participation.

With more than 35 countries represented, this immersive educational event is a realization of PLMI's mission to bring together researchers, clinicians, industry leaders, media leaders, and other stakeholders to focus on new models of healthcare delivery, advancements in medical nutrition therapy, and exciting emerging science.

Beginning on October 20, the first session focuses on advances in the management of neuroimmune disorders, with speakers including Jeffrey Bland, Ph.D., who has spent more than four decades focused on the improvement of human health and is known worldwide as the founder of the Functional Medicine movement. His pioneering work created PLMI as well as the Institute for Functional Medicine (IFM). Other topics will include the unique features of specific plant foods in managing neuroimmune disorders and genomic testing and what it says about the risk of neuroimmune disorders.

Three more engaging sessions will be covered during the event with topics including neuroimmune assessment and intervention, advances in personalizing neuroimmune interventions, and advances in repairing broken brain-behavior connections. Attendees will hear from internationally recognized experts such as Dr. Terry Wahls, Aristo Vojdani, PhD, MD, Bridget Briggs, MD, Deanna Minich, Ph.D., CNS, Dale Bredesen, MD, and more. For a full list of speakers and their topics, see the event agenda here.

The last session will also include a discussion period among faculty and attendees and end with closing comments from Dr. Bland.

PLMI looks forward to exploring these approaches to managing chronic conditions with the consortium's attendees. Space is limited at the event, and those wishing to attend can register here.

About PLMI:

The mission of the Personalized Lifestyle Medicine Institute is to bring together researchers, clinicians, industry leaders, media leaders, and other stakeholders to focus on new models of healthcare delivery, advancements in medical nutrition therapy, and exciting emerging science. Our vision encompasses building a community around dynamic collaborations, compelling dialogues, evidence-based information and resources, and immersive educational events. Since 1991, hundreds of thousands of healthcare practitioners have participated in PLMI programs, and this collective knowledge has positively impacted the lives of patients all over the world.

Contact Information

Nicole Fox
Media Management
[email protected]
(206) 201-3794

SOURCE: Personalized Lifestyle Medicine Institute (PLMI)

.


View source version on accesswire.com:
https://www.accesswire.com/775526/The-Personalized-Lifestyle-Medicine-Institute-Announces-the-11th-Annual-Thought-Leaders-Consortium

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.